PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, Hospital General de Segovia, C/Luis Erik Clavería Neurólogo S/N, 40002, Segovia, Spain. carmendcv@hotmail.com.\', \'Internal Medicine Department, Hospital General de Segovia, C/Luis Erik Clavería Neurólogo S/N, 40002, Segovia, Spain.\', \'Pharmacy Department, Hospital General de Segovia, C/Luis Erik Clavería Neurólogo S/N, 40002, Segovia, Spain.\', \'Análisis Estadísticos 3Datos SL, Salamanca, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s43440-020-00186-z
?:doi
?:hasPublicationType
?:journal
  • Pharmacological reports : PR
is ?:pmid of
?:pmid
?:pmid
  • 33165762
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The effect of tocilizumab on cytokine release syndrome in COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33165762>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33165762>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all